U.S. Supreme Court strengthens protection of pharmaceutical

Written by Sandeep Nehra

U.S. Supreme Court on Tuesday rejected the appeal by parents whose daughter had health problems after a vaccine Wyeth, strengthening the position of the pharmaceutical industry from prosecution based on side effects.

The case concerned Bruesewitz Hannah who had been a baby, three injections of a vaccine against diphtheria, tetanus and pertussis (DTP), manufactured by Wyeth, owned by the world’s number one pharmacy, the American Pfizer.

After the third injection, she began to linking unconsciousness and continued to develop normally.

The highest U.S. court upheld a previous court decision which had dismissed the complaint Bruesewitz.

The sages of the Supreme Court held, by six votes against two (one judge had recused) that the litigation side effects of vaccines should be settled under the terms established by law on child immunization.

This text has established a special court in 1986 to compensate victims of immunization, before whom the complaint had Bruesewitz, too, was rejected.

This law also protects pharmaceutical companies face the risk of prosecution, to encourage them, on behalf of public health, not to stop their research.

“Vaccine manufacturers fund an effective program compensation for victims of vaccines. In exchange, they avoid costly lawsuits that could result in disproportionate verdicts,” says the Supreme Court.

The Supreme Court’s decision thus reinforces this regime, as called for the defense of Wyeth in oral argument last December.

The law on child immunization is meant to avoid “reject vaccine manufacturers out of business” for fear of too many judicial compensation, said Wyeth’s lawyer, Kathleen Sullivan.

“We are delighted” by the decision of the Supreme Court, responded in a statement the laboratory.

“We have great respect for the family Bruesewitz. But we recall that the Act establishes that the vaccine liability issues must be resolved” before the court created by that law. However, the statement said, the Special Court had “held that the plaintiffs had failed to show that the health of their child had been caused by the vaccine.”

The decision of the Supreme Court was also “applauded” by the American Association of Pediatricians, which represents 60,000 specialists and according to this decision “protects our children by strengthening national immunization system.

• AIDS: U.S. experts to market the first preventive treatment
• KFC will pay 6.3 million euros to an intoxicated teenage girl by a chicken sandwich
• United States: a case of mad cow disease in California
• Moderate deficits in vitamin D are common in France
• Removing a dietary supplement containing a hazardous substance